Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Urelumab (Anti-TNFRSF9 / 4-1BB / CD137) For research use only.
Not for use in humans.

Urelumab (Anti-TNFRSF9 / 4-1BB / CD137)

Synonyms:

Urelumab (Anti-TNFRSF9 / 4-1BB / CD137) is a fully human agonistic monoclonal antibody targeting the CD137 receptor with potential immunostimulatory and antineoplastic activities. MW : 146.5 KD.

Urelumab (Anti-TNFRSF9 / 4-1BB / CD137)

Purity & Quality Control

Batch: A232101 Purity: 99% Protein concentration: 4.8mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Urelumab (Anti-TNFRSF9 / 4-1BB / CD137) is a fully human agonistic monoclonal antibody targeting the CD137 receptor with potential immunostimulatory and antineoplastic activities. MW : 146.5 KD.

Product Details

CAS No. 934823-49-1
Molecular Weight 146.5 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Urelumab (Anti-TNFRSF9 / 4-1BB / CD137) | Urelumab (Anti-TNFRSF9 / 4-1BB / CD137) supplier | purchase Urelumab (Anti-TNFRSF9 / 4-1BB / CD137) | Urelumab (Anti-TNFRSF9 / 4-1BB / CD137) cost | Urelumab (Anti-TNFRSF9 / 4-1BB / CD137) manufacturer | order Urelumab (Anti-TNFRSF9 / 4-1BB / CD137) | Urelumab (Anti-TNFRSF9 / 4-1BB / CD137) distributor